During the past decade, Univ. of Miami AIDS CRS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ. of Miami AIDS CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 59 trials, followed by "AIDS Clinical Trials Group" with 1 trials sponsored, "Gen-Probe, Incorporated" with 1 trials sponsored, "GeneCure Biotechnologies" with 1 trials sponsored and "Margaret A. Fischl, M.D." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. of Miami AIDS CRS" #1 collaborator was "Glaxo Wellcome" with 9 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Upjohn" with 4 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Univ. of Miami AIDS CRS" are "HIV Infections" (63 trials), "Cytomegalovirus Retinitis" (3 trials), "Pneumonia, Pneumocystis Carinii" (3 trials), "Toxoplasmosis, Cerebral" (3 trials) and "Cervix, Dysplasia" (2 trials). Many other conditions were trialed in "Univ. of Miami AIDS CRS" in a lesser frequency.

Most popular intervention types in "Univ. of Miami AIDS CRS" are "Drug" (60 trials), "Biological" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (22 trials), "Didanosine" (12 trials), "Zalcitabine" (9 trials), "Lamivudine" (7 trials) and "Stavudine" (7 trials). Other intervention names were less common.

The vast majority of trials in "Univ. of Miami AIDS CRS" are 64 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Univ. of Miami AIDS CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Univ. of Miami AIDS CRS, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Univ. of Miami AIDS CRS, 11 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".